Product Images Tolvaptan

Mean serum sodium levels (in mEq/L) comparing patients treated with tolvaptan (doses ranging between 15-80 mg) and placebo (n=213 and n=203, respectively). The results show a significant difference between the two groups (p<0.0001). The graph provided shows the serum sodium levels over time, including baseline, treatment day, and 7-day follow-up.*

This is a table showing mean serum sodium levels measured in mEq/L at various time points during a clinical trial comparing Tolvaptan (administered at doses between 15-60mg) to a placebo. There were 110 patients in the Tolvaptan group and 105 in the placebo group. The results showed a statistically significant difference between the groups (p<0.0001). The time points measured are not explicitly labeled, but appear to be on day 18, day 25, day 30, and a 7-day follow-up period.*

The text describes a graph showing the mean serum sodium levels over time (measured in mEq/L) in a group of patients who were given Tolvaptan at doses ranging from 15-80 mg. The graph shows a statistically significant decrease in serum sodium levels compared to baseline on day 1. The text does not provide any further information.*

This is a description of a medication called Tolvaptan, which is available in a tablet form of 15mg. It is distributed by Par Pharmaceutical based in Chestnut Ridge, NY 10977 USA, and manufactured in India under Mfg. Lic. No.: TNO0002121. There are also details about lot and expiration date.*

This appears to be the label of a medication package for Tolvaptan tablets containing 15mg each. The label provides information on dosage, storage, the manufacturer, and distributor. It also warns to keep the medication out of the reach of children and must be initiated in a hospital. A medication guide is enclosed that must be given to each patient. There is no information available on the Un varnish area mentioned.*

The text is displaying information related to the medication, Tolvaptan 30mg tablet, distributed by Par Pharmaceutical in the USA. The tablets were manufactured in India and the specific manufacturing license number is TNO0002121. The National Drug Code (NDC) for this product is 49884-770-52. The packaging contains information for Lot number and Expiration date as well.*

This is a medication description for Tolvaptan tablets, with each tablet containing 30mg of the medication. The package insert should be referred for information on recommended dosage and indications for use. The medication should be stored at a temperature range of 20° to 25°C (68° to 77°F), with permitted excursions to 15° to 30°C (53° to 86°F) as specified by the USP Controlled Room Temperature. It is important to keep all medications out of reach of children. The medication is distributed by Par Pharmaceutical and manufactured by Par Formulations Private Limited in India. The tablet carton contains 10 tablets and each patient should be provided with a medication guide.*